Discovery of novel N-(5-(arylcarbonyl)thiazol-2-yl)amides and N-(5-(arylcarbonyl)thiophen-2-yl)amides as potent RORγt inhibitors

Add time:07/23/2019    Source:sciencedirect.com

Novel series of N-(5-(arylcarbonyl)thiazol-2-yl)amides and N-(5-(arylcarbonyl)thiophen-2-yl)amides were discovered as potent retinoic acid receptor-related orphan receptor-gamma-t (RORγt) inhibitors. SAR studies of the RORγt HTS hit 6a led to identification of thiazole ketone amide 8h and thiophene ketone amide 9g with high binding affinity and inhibitory activity of Th17 cell differentiation. Compound 8h showed in vivo efficacy in both mouse experimental autoimmune encephalomyelitis (EAE) and collagen induced arthritis (CIA) models via oral administration.

We also recommend Trading Suppliers and Manufacturers of (2-(TRIFLUOROMETHYL)THIAZOL-5-YL)METHANOL (cas 131748-97-5). Pls Click Website Link as below: cas 131748-97-5 suppliers

Prev:Discovery of N-(4-aryl-5-aryloxy-thiazol-2-yl)-amides as potent RORγt inverse agonists
Next:Ex vivo spontaneous generation of 19-norandrostenedione and nandrolone detected in equine plasma and urine)